Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 6631 AL 6645

Carbon Nanomaterial-Based Electrochemical Biosensors for Alzheimer's Disease Biomarkers: Progress, Challenges, and Future Perspectives

Şak B, Sousa HBA, Prior JAV.

Biosensors (Basel). 2025 Oct 9;15(10):684. doi: 10.3390/bios15100684.

The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseases

Agnello L, Gambino CM, Ciaccio AM, Salemi G, Brighina F, Ragonese P, Piccoli T, Blandino V, Di Stefano V, Cacciabaudo F, Masucci A, Vassallo R, Scazzone C, Del Ben F, Ciaccio M.

Clin Chim Acta. 2025 May 15;572:120248. doi: 10.1016/j.cca.2025.120248. Epub 2025 Mar 18.

Clinical definition, biological characterization, and detection guidelines of subjective cognitive decline due to Alzheimer's disease and related dementia: A position paper from ISTAART SCD PIA

Moretti DV, Kuhn E, Dubbelmann MA, Sikkes SAM, Castilhos RM, Chapman S, Gifford KA, Butterbrod E, Nosheny RL; Subjective Cognitive Decline Professional Interest Area, Alzheimer's Association ISTAART.

Alzheimers Dement. 2025 Dec;21(12):e70847. doi: 10.1002/alz.70847.

Recent advances in nanomaterial-based biosensors for Alzheimer's disease diagnosis: a review

Liu Q, Xu X, Zheng T.

Chem Commun (Camb). 2025 Sep 4;61(72):13503-13522. doi: 10.1039/d5cc02469b.

The Role of circRNAs in the Pathological Mechanisms of Alzheimer's Disease: Potential Biomarkers for Diagnosis

Abuduwaili Z, Fan Y, Tao W, Chen Y, Xu Y, Zhu X.

Curr Neuropharmacol. 2025;23(6):635-649. doi: 10.2174/011570159X337659241014140824.

Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia

Vollhardt A, Frölich L, Stockbauer AC, Danek A, Schmitz C, Wahl AS.

Neurobiol Dis. 2025 May;208:106845. doi: 10.1016/j.nbd.2025.106845. Epub 2025 Feb 24.

Boston University Alzheimer's Disease Research Center Clinical Core: Infrastructure to facilitate research on post-traumatic Alzheimer's disease and related dementias

Alosco ML, Morrison M, Au R, Steinberg EG, Mwicigi J, Ly M, Altaras C, Lenio S, Abdennadher M, O'Connor MK, Tripodis Y, Palmisano J, Dixon D, Martin B, Schneider G, Groh JR, Ellison A, Sheppard D, Farris CW, Nowinski C, Cantu RC, Turk KW, Farrer L, Jun G, Goldstein LE, Qiu WQ, Stein TD, Budson AE, McKee AC, Mez J.

Alzheimers Dement. 2025 Sep;21(9):e70654. doi: 10.1002/alz.70654.

Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer's Disease and Mild Cognitive Impairment. Systematic Review and Meta-Analysis

Serna MF, Mosquera M, García-Perdomo HA.

Neuromolecular Med. 2025 Jul 25;27(1):53. doi: 10.1007/s12017-025-08866-w.

Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer's Disease

Pokrzyk J, Kulczyńska-Przybik A, Guzik-Makaruk E, Winkel I, Mroczko B.

Int J Mol Sci. 2025 Feb 24;26(5):1935. doi: 10.3390/ijms26051935.

Recent molecular insights and biosensor-based diagnostic technologies for hyperphosphorylated Tau in Alzheimer's disease

Shabana S, Hamouda HI, Shang A, Shao S, Zhao J, Yuan H, Liu B.

Alzheimers Res Ther. 2025 Dec 17;18(1):5. doi: 10.1186/s13195-025-01932-2.

The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery

Videla L, Benejam B, Barroeta I, Fernandez S, Altuna M, Arranz J, Rodríguez-Baz Í, Arriola-Infante JE, Maure-Blesa L, Del Hoyo Soriano L, Illán-Gala I, Estellés T, Sanjuan A, Vaqué-Alcázar L, Aranha MR, Morcillo-Nieto AO, Zsadanyi SE, Franquesa-Mullerat M, Valldeneu S, Sánchez-Saudinós MB, Padilla C, Carreras M, Lorente O, Valle-Tamayo N, Sánchez-Aced É, Dols-Icardo O, Sirisi S, Muñoz L, Torres S, Bounasr El Bennadi SE, Sánchez O, Garzón D, Ribas L, Elbachiri S, Mota C, Tondo M, Camacho V, Giménez S, Delaby C, Belbin O, Iulita MF, Montal V, Pegueroles J, Vilaplana E, Clarimón J, González-Ortiz S, Molina-Porcel L, Aldecoa I, Alcolea D, Bejanin A, Videla S, Blesa R, Lleó A, Carmona-Iragui M, Fortea J.

Alzheimers Dement. 2025 Jun;21(6):e70259. doi: 10.1002/alz.70259.

Analytical considerations and clinical utility of plasma phosphorylated Tau217

Frykman H.

Crit Rev Clin Lab Sci. 2026 Mar;63(2):124-134. doi: 10.1080/10408363.2025.2551648. Epub 2025 Sep 15.

The moderating effect of cognitive reserve on the association between neuroimaging biomarkers and cognition: A systematic review

Guo L, Zhou Y, Lu H, Fung HH.

Neurobiol Aging. 2025 Dec;156:10-29. doi: 10.1016/j.neurobiolaging.2025.07.016. Epub 2025 Jul 30.

Utilizing machine learning algorithms to identify biomarkers associated with Alzheimer's disease and ferroptosis-related genes

Wang D, Lin C, Liu G, Wang X, Han S, Han Z.

Technol Health Care. 2025 Jul;33(4):2041-2063. doi: 10.1177/09287329251322278. Epub 2025 Mar 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias